Reply to : Rong Dai and Changkai Deng’s Letter to the Editor re: Anirban Dey, Georgios Georgiadis, Justin Umezurike, et al. Mirabegron Versus Placebo and Other Therapeutic Modalities in the Treatment of Patients with Overactive Bladder Syndrome—A Systematic Review. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2024.09.012. European Urology Focus
| dc.contributor.author | Dey, Anirban | |
| dc.contributor.author | Georgiadis, Georgios | |
| dc.contributor.author | Umezurike, Justin | |
| dc.contributor.author | Yuan, Yuhong | |
| dc.contributor.author | Farag, Fawzy | |
| dc.contributor.author | N'Dow, James | |
| dc.contributor.author | Omar, Muhammad Imran | |
| dc.contributor.author | Mamoulakis, Charalampos | |
| dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
| dc.contributor.institution | University of Aberdeen.Academic Urology Unit | en |
| dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
| dc.date.accessioned | 2025-05-27T15:46:01Z | |
| dc.date.available | 2025-05-27T15:46:01Z | |
| dc.date.issued | 2025-01-09 | |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 2 | |
| dc.format.extent | 801396 | |
| dc.identifier | 300342167 | |
| dc.identifier | 90d34038-07e7-4579-9934-825a4cc00866 | |
| dc.identifier | 85217261368 | |
| dc.identifier | 39788825 | |
| dc.identifier.citation | Dey, A, Georgiadis, G, Umezurike, J, Yuan, Y, Farag, F, N'Dow, J, Omar, M I & Mamoulakis, C 2025, 'Reply to : Rong Dai and Changkai Deng’s Letter to the Editor re: Anirban Dey, Georgios Georgiadis, Justin Umezurike, et al. Mirabegron Versus Placebo and Other Therapeutic Modalities in the Treatment of Patients with Overactive Bladder Syndrome—A Systematic Review. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2024.09.012. European Urology Focus', European Urology Focus. https://doi.org/10.1016/j.euf.2024.12.004 | en |
| dc.identifier.doi | 10.1016/j.euf.2024.12.004 | |
| dc.identifier.issn | 2405-4569 | |
| dc.identifier.other | ORCID: /0000-0001-5340-0081/work/176746939 | |
| dc.identifier.other | ORCID: /0000-0002-1597-3126/work/176747587 | |
| dc.identifier.uri | https://hdl.handle.net/2164/25513 | |
| dc.language.iso | eng | |
| dc.relation.ispartof | European Urology Focus | en |
| dc.subject | R Medicine | en |
| dc.subject.lcc | R | en |
| dc.title | Reply to : Rong Dai and Changkai Deng’s Letter to the Editor re: Anirban Dey, Georgios Georgiadis, Justin Umezurike, et al. Mirabegron Versus Placebo and Other Therapeutic Modalities in the Treatment of Patients with Overactive Bladder Syndrome—A Systematic Review. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2024.09.012. European Urology Focus | en |
| dc.type | Journal item | en |
Files
Original bundle
1 - 1 of 1